Rotavirus Infections: Clinical Trials

17 trials for Rotavirus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 2 withdrawn, 1 active not recruiting, 1 unknown. 17 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Completed 13, Withdrawn 2, Active not recruiting 1, Unknown 1
Phase 11Withdrawn 1
Phase 31Completed 1

Follow Rotavirus Infections: new trials by email Literature Review of Rotavirus Infections trials Research Report on Rotavirus Infections

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Clinical Trial of the Inactivated Rotavirus Vaccine
IRV on a 0- and 28-day schedule, IRV on a 0-, 28- and 56-day schedule, Placebo on Day 0, 28 - Rotavirus Infections, Diarrhea
Phase 2UnknownInstitute of Medical Biology, Chinese Academy of Medical Sciences6002023-10-202024-01-03
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine, High dose Recombinant Trivalent Subunit Rotavirus Vaccine, Placebo - Rotavirus Infections, Rotavirus Gastroenteritis
Phase 2Active not recruitingMAXVAX Biotechnology Limited Liability Company15122023-01-082024-11-20
A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine
RV3-BB, Placebo - Rotavirus Infections
Phase 2CompletedMurdoch Childrens Research Institute7112018-06-152023-07-10
Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine
251154 vaccine, Infanrix hexa™, Synflorix™ - Infections, Rotavirus
Phase 2WithdrawnGlaxoSmithKline2010-04-012015-03-27
Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers
RotaTeq, Placebo - HIV Infection, Rotavirus Infection
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2022009-12-012021-11-05
Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants
Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV], Placebo - Rotavirus Infections
Phase 1 / Phase 2WithdrawnShantha Biotechnics Limited2402009-09-012010-02-03
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.
Rotarix™, Placebo - Infections, Rotavirus, Rotavirus Vaccines
Phase 2CompletedGlaxoSmithKline3752007-03-092020-01-02
Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children
Nitazoxanide - Rotavirus Infection, Viral Gastroenteritis Due to Rotavirus
Phase 2CompletedRomark Laboratories L.C.1002005-12-012011-04-05
Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis
Live attenuated rotavirus vaccine - Infections, Rotavirus
Phase 2CompletedGlaxoSmithKline2502005-08-012016-09-21
A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh
Rotavirus - Infections, Rotavirus
Phase 2CompletedGlaxoSmithKline3002005-06-012016-09-21
A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa
Rotarix, Placebo, Tritanrix-HB+Hib - Infections, Rotavirus
Phase 2CompletedGlaxoSmithKline1002005-03-162020-11-23
Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children
Alinia (nitazoxanide) - Rotavirus Infection, Adenoviridae Infection
Phase 2 / Phase 3CompletedRomark Laboratories L.C.502005-02-012012-05-31
Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa
HRV vaccine - Infections, Rotavirus
Phase 2CompletedGlaxoSmithKline4722003-09-012016-09-15
To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV
Rotavirus (vaccine) - Rotavirus Infections
Phase 2CompletedGlaxoSmithKline4502001-11-012016-09-09
Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months
HRV vaccine - Infections, Rotavirus
Phase 2CompletedGlaxoSmithKline26402001-05-312019-12-27
Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.
Human Rotavirus Vaccine - two different formulations, Prevnar, IPOL - Infections, Rotavirus
Phase 2CompletedGlaxoSmithKline5292000-11-012016-09-16
Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants
Rotarix - Infections, Rotavirus
Phase 2CompletedGlaxoSmithKline4052000-08-012016-09-16

Narrower conditions

Gastroenteritis (4)  ·  Adenoviridae Infections (1)  ·  Caliciviridae Infections (1)  ·  Diarrhea (1)  ·  HIV Infections (1)

Broader conditions

Infections (17)  ·  RNA Virus Infections (17)  ·  Reoviridae Infections (17)  ·  Virus Diseases (17)  ·  Digestive System Diseases (4)  ·  Gastrointestinal Diseases (4)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  DNA Virus Infections (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Lentivirus Infections (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Retroviridae Infections (1)

Interventions

RIX4414 vaccine (4)  ·  nitazoxanide (2)  ·  Appointments and Schedules (1)  ·  Diphtheria-Tetanus-acellular Pertussis Vaccines (1)  ·  Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1)  ·  Heptavalent Pneumococcal Conjugate Vaccine (1)  ·  PHiD-CV vaccine (1)  ·  RotaTeq (1)  ·  Rotavirus Vaccines (1)  ·  diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (1)  ·  pentacel (1)

Sponsors

GlaxoSmithKline (10)  ·  Romark Laboratories L.C. (2)  ·  Institute of Medical Biology, Chinese Academy of Medical Sciences (1)  ·  MAXVAX Biotechnology Limited Liability Company (1)  ·  Murdoch Childrens Research Institute (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Shantha Biotechnics Limited (1)

Countries

South Africa (3)  ·  China (2)  ·  Bangladesh (1)  ·  Botswana (1)  ·  Egypt (1)  ·  Finland (1)  ·  India (1)  ·  Malawi (1)  ·  Philippines (1)  ·  Tanzania (1)  ·  Zambia (1)  ·  Zimbabwe (1)

Top investigators

Mona Abu-Zekry, MD (2)  ·  Yanxia Wang (2)  ·  Desiree Witte, MD MTropPaed (1)  ·  Myron J. Levin, MD (1)  ·  Raman Rao, MD (1)

Results publications

PMID 16394298, PMID 16829296, PMID 21238572, PMID 27662551, PMID 39339964

NIH funding

2015 (2)